Novel biomarkers for prostate cancer including noncoding transcripts.
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerPotential prognostic, diagnostic and therapeutic markers for human gastric cancerValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelc-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cellsCharacterization of niphatenones that inhibit androgen receptor N-terminal domainCandidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and bloodGlo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypesGlyoxalase-I is a novel prognosis factor associated with gastric cancer progressionSpondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.MicroRNA profile in very young women with breast cancerDifferential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.Exacerbated experimental colitis in TNFAIP8-deficient mice.Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers.Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patientsValidation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy.Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.Regulators of gene expression as biomarkers for prostate cancerUnscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrationsAssociation between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinomaPhospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.Spongian diterpenoids inhibit androgen receptor activityRAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer.Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.Lipids and prostate cancer.Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease.Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis.MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8.Store-operated Ca2+ Entry-associated Regulatory factor (SARAF) Plays an Important Role in the Regulation of Arachidonate-regulated Ca2+ (ARC) Channels.Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients.Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.Over-expression of cofilin-1 and phosphoglycerate kinase 1 in astrocytomas involved in pathogenesis of radioresistance.
P2860
Q21202034-2F0728B7-64FF-4143-8915-5B14F59D206FQ26866200-7882C3CF-11CD-43BB-8BEE-6EA7160556E9Q27001399-71B659CD-FD2C-41A1-A930-816B31D0F70DQ28270073-6C2A0F42-1F04-4E62-B7CF-8276AA4B50F4Q28543404-32945CBE-FF00-4962-A71A-23AA4C07D82AQ31045532-D10E6074-A179-4C88-8DD8-D5E3B32B6D8FQ33802709-BBFB0041-01C6-49CA-B61B-ACF78FA017FAQ34221728-C2AA0031-EBF0-4FFA-970F-B50C5678745EQ34222449-3519795C-BE53-47E7-AB87-033F303950D1Q34276511-965A9605-42F1-4AD1-BD13-B6923D2821EDQ34465132-5BD5928D-56C7-40A9-9244-3A0F89C0F912Q34468715-DB67BF28-4B00-4A01-A6F6-E2F03D4999A9Q34607780-9430BFF6-2D8B-4954-9BB2-D8447CA09C7CQ35091466-A8E89756-DEC0-4C7C-B551-2C9A77588F1DQ35691053-C1B9D239-D35D-46A6-AE41-62C9BF5453ACQ35771477-F8B8E423-6F99-479B-9130-72F437D3AD51Q36020932-9A7CCDEF-A6D9-4538-89BF-54ED15CD5F3FQ36022437-C2CBC892-70AE-4890-9D46-29309F808C82Q36084372-70DDDCAD-DC83-4B6A-8D11-94071F389E62Q36363019-D698E20F-31A7-403F-9613-0456F8E68ECBQ36439912-C0C05EDE-6D2D-49CE-BEF9-CB3A425938D2Q36905633-75B78EDA-2FE3-439F-A355-E7D2DB234CE0Q37001794-E69F79F4-8F93-4321-A598-0D69CE237C4EQ37022229-0207035A-2E33-48E0-8AF4-DABD0CFAFAF7Q37058937-8A2238B1-1E98-4208-A703-E0A4BBF569ABQ37149065-70F34BF5-DA4C-4EE8-BE32-81F07A0F1B22Q37631704-2C71B5CB-969C-4F0B-A928-85F725FA6E11Q37705831-BE02EAC9-F342-4DF9-ACD8-40A4E0C6E04CQ38002682-4766A262-89C5-4812-8C90-16446643E62BQ38433418-6EAFD896-7F1E-4A73-8404-9418D1151FBEQ38708426-F464E96E-0298-4D7D-B295-92355A11AFCFQ38719196-F65FEBAD-1ECA-4F2E-A737-993B602CAC66Q38799096-D33D3552-48A3-4139-8A0C-41F4B068B0DCQ39214172-0F18771A-E81B-4FAB-97B5-EDA67235888AQ40685281-5A2808E4-A375-43F9-B557-962C216F394DQ42122998-8B8FF6F3-4272-45E5-9522-CC3DF2C032F4Q43185634-74DA8AF0-547A-4D40-B3CE-D6056B94FE42Q47678239-481770F2-ED83-4E91-B74E-C501B2ACE399Q47773922-92D4F400-4064-461E-B6A2-F2D8DA8E1094Q48458127-05C0AF49-D7F7-46CD-A4F5-2AAC4FCD58C5
P2860
Novel biomarkers for prostate cancer including noncoding transcripts.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel biomarkers for prostate cancer including noncoding transcripts.
@ast
Novel biomarkers for prostate cancer including noncoding transcripts.
@en
Novel biomarkers for prostate cancer including noncoding transcripts.
@nl
type
label
Novel biomarkers for prostate cancer including noncoding transcripts.
@ast
Novel biomarkers for prostate cancer including noncoding transcripts.
@en
Novel biomarkers for prostate cancer including noncoding transcripts.
@nl
prefLabel
Novel biomarkers for prostate cancer including noncoding transcripts.
@ast
Novel biomarkers for prostate cancer including noncoding transcripts.
@en
Novel biomarkers for prostate cancer including noncoding transcripts.
@nl
P2093
P2860
P1476
Novel biomarkers for prostate cancer including noncoding transcripts.
@en
P2093
Marianne D Sadar
Robert L Vessella
Simon Haile
Takeshi Ueda
Tammy L Romanuik
Theresa M K Yong
Thomas Thomson
P2860
P304
P356
10.2353/AJPATH.2009.080868
P407
P577
2009-11-05T00:00:00Z